G1 Therapeutics Inc (NASDAQ: GTHX) is -15.90% lower on its value in year-to-date trading and has touched a low of $1.08 and a high of $6.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GTHX stock was last observed hovering at around $2.45 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $2.57, the stock is -3.55% and -27.90% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.51 million and changing 4.69% at the moment leaves the stock -13.24% off its SMA200. GTHX registered 3.85% gain for a year compared to 6-month gain of -17.52%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -20.59% loss in the last 1 month and extending the period to 3 months gives it a -45.66%, and is 14.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.25% over the week and 10.98% over the month.
G1 Therapeutics Inc (GTHX) has around 100 employees, a market worth around $134.10M and $84.04M in sales. Profit margin for the company is -36.40%. Distance from 52-week low is 137.50% and -58.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.41%).
The EPS is expected to grow by 43.95% this year
The shares outstanding are 51.93M, and float is at 43.56M with Short Float at 11.24%.
G1 Therapeutics Inc (GTHX) Insider Activity
The most recent transaction is an insider sale by Thomas Monica R., the company’s Chief Legal & People Officer. SEC filings show that Thomas Monica R. sold 5,826 shares of the company’s common stock on May 23 ’24 at a price of $4.27 per share for a total of $24864.0. Following the sale, the insider now owns 0.11 million shares.
G1 Therapeutics Inc disclosed in a document filed with the SEC on May 13 ’24 that Bailey John E. (Jack) Jr. (President and CEO) sold a total of 37,258 shares of the company’s common stock. The trade occurred on May 13 ’24 and was made at $4.79 per share for $0.18 million. Following the transaction, the insider now directly holds 0.45 million shares of the GTHX stock.
Still, SEC filings show that on May 13 ’24, MURDOCK TERRY L (Chief Operating Officer) disposed off 8,151 shares at an average price of $4.79 for $39034.0. The insider now directly holds 95,487 shares of G1 Therapeutics Inc (GTHX).
